Results 61 to 70 of about 38,837 (270)

Monitoring and metabolic risks with second generation antipsychotics [PDF]

, 2013
As the armamentarium of antipsychotic medications continues to grow, so does data supporting expansion of their use for conditions beyond schizophrenia.
Reiss, Rebecca
core  

Fluphenazine decanoate (depot) and enanthate for schizophrenia [PDF]

, 2015
Background: Intramuscular injections (depot preparations) offer an advantage over oral medication for treating schizophrenia by reducing poor compliance.
Abuzzahab, Abuzzahab, Abuzzahab, Adamson, Ahlfors, Alarcon, Alarcon, Albert, Altamura, Altamura, Altman, Andreasen, Andreasen, Angst, Angst, Arato, Asarnow, Asberg, Astrup, Balon, Bankier, Bao, Barnes, Barnes, Barnes, Barsa, Bastie, Benassi, Berliner, Bilone, Bland, Bloch, Boissel, Boyer, Breier, Buck, Caranza, Carpenter, Carpenter, Carpenter, Cassady, Chacon, Chacon, Charalampous, Chein, Chien, Childers, Chouinard, Chouinard, Chouinard, Chouinard, Chouinard, Chouinard, Chowdhury, Clark, Cohen, Cole, Cookson, Cookson, Coufal, Crawford, Curry, Curry, Curson, Curson, David, David, Davis, Dencker, Dencker, Dencker, Dencker, Dencker, Dencker, Dengler, DeWolfe, Divine, Donlon, Donlon, Donlon, Donlon, Donner, Doongaji, Dossenbach, Dotti, Downing, Egger, Elbourne, Endicott, Engelhardt, Engstrand, Fallon, Falloon, Faltus, Faretra, Feighner, Feng, Filip, Floru, Floru, Frangos, Furukawa, Gelenberg, Giannelli, Gillis, Gitlin, Gitlin, Giudice, Goff, Goldberg, Goldberg, Goldberg, Goldberg, Goldstein, Gopalakrishnan, Grosser, Gulliford, Guy, Haider, Hall, Hamilton, Hanlon, Harper, Haslam, Haynes, Heinrich, Held, Higgins, Hirsch, Hirsch, Hirsch, Hirsch, Hirsch, Hirsch, Hogarty, Hogarty, Hogarty, Holden, Holt, Honigfeld, Hsu, Hutton, Inderbitzin, Inderbitzin, Ionescu, Iqbal, Irwin, Itil, Itil, Itil, Itil, Jablensky, Jain, Jakovljevic, James, Javed, Johnson, Jolley, Jones, Ju, Jue, Kabes, Kabes, Kabes, Kabes, Kane, Kane, Kane, Kane, Kane, Kane, Kane, Kane, Kaneno, Kay, Kelly, Kenway, Keskiner, Keskiner, Keskiner, Khazaei, Khazaie, King, Kinon, Kinross-Wright, Kissling, Knights, Kong, Krawiecka, Kreisman, Kurland, Kurland, Landmark, Lapierre, Lapierre, Lapierre, Lapierre, Lasky, Leff, Leff, Lehmann, Leong, Leucht, Leucht, Levenson, Levine, Levinson, Levinson, Levinson, Lewis, Lewis, Lingjaerde, Litman, Ljubin, Lundin, Lundin, MacCrimmon, Magnus, Magnus, Mahmoud, Malm, Mandel, Marder, Marder, Marder, Marder, Marder, Marder, Marder, Marder, Marder, Marder, Marder, Marshall, Martenyi, Martin, Mattes, McClelland, McCreadie, McCreadie, McCreadie, McCreadie, McKane, McLaren, Meco, Mimica, Moher, Montejo, Morris, National Institute of Mental Health Psychopharmacology Service Center Collaborative Study Group, Nestoros, Odejide, Overall, Owen, Palma Wenzel, Pichot, Pickar, Pickar, Pickar, Pinto, Pollack, Praag, Praag, Preussler, Preussler, Putten, Putten, Quitkin, Quitkin, Quitkin, Ravanic, Ravaris, Ravaris, Rifkin, Rifkin, Rifkin, Rifkin, Rifkin, Roose, Rossger, Rossi, Russell, Schausberger, Schipper, Schlosberg, Schneider, Schooler, Schooler, Schooler, Schooler, Schooler, Schooler, Schooler, Schubert, Schünemann, Shafti, Sharma, Shenoy, Shepherd, Shu, Simon, Simpson, Simpson, Singh, Song, Steingard, Stevens, Stevens, Tegeler, Tran, Tretreault, Tsai, Tsai, Turner, Turner, Ukoumunne, Ushakov, Ushakov, Verster, Vestre, Viala, Villeneuve, Vinar, Walker, Weiden, Wiles, Winter, Wistedt, Wistedt, Wistedt, Wistedt, Wistedt, Wistedt, Wistedt, Woggon, Xia, Zapletalek   +336 more
core   +1 more source

Association Between D‐amino Acids in Natto (fermented soybeans) and Kidney Dysfunction

ChemFoodChem, EarlyView.
XX XX ABSTRACT In this study, we examined clinical and cohort data to explore the potential renoprotective effects of natto (fermented soybeans) consumption and its relationship with D‐amino acids. In a clinical study, ten healthy adults consumed one 40‐g pack of natto three times in a single day, and plasma and urine samples were collected 1 h and 24 ...
Yusuke Nakade, Tadashi Toyama, Akinori Hara, Shigefumi Okamoto, Hiroaki Masuoka, Wataru Suda, Masashi Mita, Yuna Miyajima, Keishi Mizuguchi, Takeo Yuno, Hiroka Yamazaki, Hiroki Ohtani, Hoang Thuy Linh, Megumi Oshima, Miho Shimizu, Norihiko Sakai, Hiromasa Tsujiguchi, Hiroyuki Nakamura, Yasunori Iwata, Takashi Wada   +19 more
wiley   +1 more source

Can We Really Prevent Suicide? [PDF]

, 2012
Every year, suicide is among the top 20 leading causes of death globally for all ages. Unfortunately, suicide is difficult to prevent, in large part because the prevalence of risk factors is high among the general population. In this review, clinical and
A Fagiolini, A Roy, A Roy, AC Leon, AD Lopez, AF Jorm, AL Beautrais, AN Sabo, AP Chioqueta, B Schneider, B Schneider, B Spivac, B Stanely, B Stanley, B Yerevanian, BA Palmer, BN Gaynes, C Bushe, C Haw, CM Feltz-Cornelis van der, CW Tsai, D Fergusson, D Gunnell, D Shaffer, D Wasserman, DA Brent, DA Brent, DA Brent, EC Harris, F Cassidy, F Guzzetta, F Keller, FK Goodwin, FS Bridges, G Dieserud, G Isacsson, G Isacsson, G Sonneck, Gil Zalsman, GK Brown, GL Carter, GL Sidley, H Dumesnil, H Galfalvy, H Valtonen, HG Morgan, HJ Moller, HJ Moller, HJ Moller, HY Meltzer, J Fawcet, J Johnson, J Lonnqvist, JA Egeland, JB Luoma, JD Maser, JJ Lin, JJ Mann, JJ Mann, JM Boden, JMG Williams, K Hawton, K Hor, K Posner, K Szanto, KL Knox, KM Malone, L Tondo, LM Hayes, Lucas Giner, M Bauer, M Bauer, M Leitner, M Miller, M Olfson, M Panagioti, M Pompili, M Sarchiapone, M Shelef, MA Oquendo, MA Oquendo, MA Oquendo, MA Oquendo, Maria A. Oquendo, Maya Schwartz-Lifshitz, MD Rudd, MM Linehan, MP Pignone, N Tarrier, ND Kapusta, NM Melhem, O Bennewith, PA Wyman, PG Placidi, PH Soloff, PH Soloff, RD Gibbons, RJ Baldessarini, S Kelly, SH Kennedy, SP Pirkola, U Hegerl, U Hegerl, U Hegerl, UA Andersen, W Coryell, WA Watson, WD Hall, Z Rihmer, Z Rihmer, Z Rihmer, Z Rihmer   +111 more
core   +1 more source

The Prevalence and Implications of Polypharmacy in Individuals With Type 1 Diabetes

Clinical Pharmacology &Therapeutics, EarlyView.
Polypharmacy is increasingly recognized as a relevant issue in diabetes care, but its prevalence and clinical relevance in individuals with type 1 diabetes remain underexplored. This study aimed to determine the prevalence of polypharmacy and to identify associated clinical and psychological factors. Participants were recruited from a tertiary diabetes
Namam Ali, Stephan van Erp, Cornelis Kramers, Cornelis J. Tack, Bastiaan E. de Galan   +4 more
wiley   +1 more source

Atypical antipsychotics induced chronic akathisia: a case report

Psychiatry and Behavioral Sciences, 2014
Akathisia is a movement disorder characterized by involuntary movements resulting in discomfort and restlessness. The four subtypes of akathisia are as follows: acute, tardive, withdrawal and chronic akathisia.
Serap Oflaz, Hasan Bakay, Ertuğrul Cekic, Hulya Guveli, Sevda Bağ   +4 more
doaj   +1 more source

Metabolic Syndrome Screening in Seriously Mentally Ill Patients: A Quality Improvement Project [PDF]

, 2016
A Project Submitted in Partial Fulfillment of the Requirements for the Degree of MASTER OF SCIENCE in Nursing ScienceSeriously mentally ill patients who are taking second-generation antipsychotics have a high risk of metabolic complications ...
Moreno, Annabel
core  

An in vivo biosensor for neurotransmitter release and in situ receptor activity. [PDF]

, 2010
Tools from molecular biology, combined with in vivo optical imaging techniques, provide new mechanisms for noninvasively observing brain processes. Current approaches primarily probe cell-based variables, such as cytosolic calcium or membrane potential ...
Griesbeck, Oliver, Kleinfeld, David, Mank, Marco, Muller, Arnaud, Nguyen, Quoc-Thang, Schroeder, Lee F, Taylor, Palmer   +6 more
core   +2 more sources

Pharmacogenomics of Major Depressive Disorder in Indigenous Amazonian Populations

Clinical Pharmacology &Therapeutics, EarlyView.
Major depressive disorder is a highly prevalent psychological disorder worldwide and its main treatment is the use of Selective Serotonin Reuptake Inhibitors. However, few studies have demonstrated the relationship between the presence of genetic variants in pharmacogenes and the efficacy of these drugs, especially in populations with a unique genetic ...
Kaio Evandro Cardoso Aguiar, Natasha Monte da Silva, Juliana Carla Gomes Rodrigues, André Maurício Ribeiro‐dos‐Santos, Sandro José de Souza, Ândrea Ribeiro‐dos‐Santos, João Farias Guerreiro, Sidney Emanuel Batista dos Santos, Marianne Rodrigues Fernandes, Ney Pereira Carneiro dos Santos   +9 more
wiley   +1 more source

Antipsychotics for the treatment of bipolar disorder

Psychiatry and Clinical Psychopharmacology, 2021
Antipsychotics are commonly used in bipolar disorders both for the treatment of acute episodes and of maintenance. However, the use of typical antipsychotics in bipolar episodes is associated with a number of limitations.
Cengiz Tuğlu
doaj